bf/NYSE:RCUS_icon.jpeg

COM:ARCUSBIO

Arcus Biosciences

  • Stock

USD

Last Close

14.28

22/11 21:00

Market Cap

1.27B

Beta: -

Volume Today

534.33K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-17.97M
-
-53.08M
195.39%
-49.59M
6.57%
-84.71M
70.81%
-122.86M
45.03%
52.83M
143.00%
-267M
605.39%
-307M
14.98%
depreciation and amortization
1.31M
-
2.61M
98.78%
3.66M
40.28%
3.58M
2.35%
4.19M
17.13%
3.84M
8.30%
6M
56.13%
8M
33.33%
deferred income tax
-90K
-
416K
562.22%
-2.10M
603.61%
4.77M
-
-19M
-
stock based compensation
90K
-
495K
450%
3.87M
682.63%
8.98M
131.83%
21.82M
143.01%
54.53M
149.84%
65M
19.20%
73M
12.31%
change in working capital
3.62M
-
24.60M
579.13%
1.33M
94.58%
125K
90.62%
208.06M
166,346.40%
-375.62M
280.54%
623M
265.86%
-71M
111.40%
accounts receivables
-132K
-
-917K
594.70%
-17.05M
1,758.89%
704M
4,230.00%
15M
97.87%
inventory
1.07M
-
21.32M
1,894.76%
14.09M
33.95%
-704M
5,098.23%
-15M
97.87%
accounts payables
3.57M
-
-267K
107.48%
-69K
74.16%
1.73M
2,601.45%
9.27M
437.20%
-4.77M
151.48%
8M
267.61%
-1M
112.50%
other working capital
53K
-
24.86M
46,815.09%
1.40M
94.37%
-2.54M
281.16%
178.38M
7,128.33%
-367.88M
306.24%
615M
267.17%
-70M
111.38%
other non cash items
90K
-
-98K
208.89%
-177K
80.61%
-1.44M
711.30%
-46K
96.80%
3.47M
7,652.17%
11M
216.64%
10M
9.09%
net cash provided by operating activities
-12.94M
-
-25.06M
93.60%
-43.00M
71.58%
-73.46M
70.86%
111.17M
251.33%
-256.17M
330.43%
438M
270.98%
-306M
169.86%
investments in property plant and equipment
-4.10M
-
-5.51M
34.52%
-3.74M
32.12%
-1.93M
48.57%
-3.06M
58.70%
-26.08M
753.62%
-12M
53.98%
-24M
100%
acquisitions net
-1M
-
-61.14M
-
431M
804.97%
-22M
105.10%
purchases of investments
-33.76M
-
-96.83M
186.80%
-261.55M
170.11%
-247.75M
5.28%
-739.66M
198.54%
-718.87M
2.81%
-1.24B
72.63%
-788M
36.50%
sales maturities of investments
1M
-
53.27M
5,227.30%
151.85M
185.05%
308.89M
103.41%
308.35M
0.18%
741.08M
140.34%
837M
12.94%
1.01B
20.19%
other investing activites
-1M
-
61.14M
-
-431M
804.97%
22M
105.10%
3M
86.36%
net cash used for investing activites
-38.86M
-
-49.07M
26.27%
-113.44M
131.18%
59.21M
152.20%
-434.37M
833.58%
-3.87M
99.11%
-413M
10,577.35%
194M
146.97%
debt repayment
-5M
-
-10M
100%
common stock issued
892K
-
125.11M
13,925.90%
1.22M
99.03%
433.78M
35,543.06%
220.24M
49.23%
23M
89.56%
33M
43.48%
common stock repurchased
-94K
-
-54K
42.55%
-6K
88.89%
dividends paid
-5M
-
other financing activites
70.10M
-
106.50M
51.93%
3.96M
96.28%
1.12M
71.66%
4.95M
341.05%
27.11M
447.37%
20M
26.23%
net cash used provided by financing activities
70.10M
-
107.40M
53.20%
129.07M
20.19%
1.12M
99.13%
438.68M
38,962.78%
237.34M
45.90%
33M
86.10%
33M
0%
effect of forex changes on cash
net change in cash
18.30M
-
33.27M
81.83%
-27.36M
182.25%
-13.13M
52.02%
115.48M
979.70%
-22.70M
119.66%
58M
355.52%
-79M
236.21%
cash at beginning of period
46.87M
-
65.16M
39.04%
98.43M
51.05%
71.27M
27.59%
58.14M
18.42%
173.62M
198.62%
151M
13.03%
209M
38.41%
cash at end of period
65.16M
-
98.43M
51.05%
71.06M
27.80%
58.14M
18.19%
173.62M
198.62%
150.92M
13.07%
209M
38.48%
130M
37.80%
operating cash flow
-12.94M
-
-25.06M
93.60%
-43.00M
71.58%
-73.46M
70.86%
111.17M
251.33%
-256.17M
330.43%
438M
270.98%
-306M
169.86%
capital expenditure
-4.10M
-
-5.51M
34.52%
-3.74M
32.12%
-1.93M
48.57%
-3.06M
58.70%
-26.08M
753.62%
-12M
53.98%
-24M
100%
free cash flow
-17.04M
-
-30.57M
79.39%
-46.74M
52.88%
-75.39M
61.29%
108.11M
243.41%
-282.25M
361.06%
426M
250.93%
-330M
177.46%

All numbers in USD (except ratios and percentages)